Internal Medicine, Nephrology · Newport Beach, CA
NPI
1659469526
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1501 Superior Ave, Suite 205
Newport Beach, CA, 92663
Phone (949) 642-4974
Groups this clinician bills Medicare through
Medicare paid, 2024
$340K
2,915 services
Medicare patients, 2024
936
Average age 75
Drug cost, 2024
$1.2M
3,237 prescriptions
Company payments, 2025
$13K
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eric Wechsler was code 99215 (office e&m - established), 947 times for 548 patients. In total Eric Wechsler billed 2,915 services in 34 codes, and Medicare paid $340K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-01-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 947 | 548 | $118.37 | $112K |
| 99214 Office E&M - Established | Office | 820 | 461 | $74.90 | $61K |
| 99233 Hospital E&M - Subsequent | Facility | 235 | 109 | $94.37 | $22K |
| 99205 Office E&M - New | Office | 129 | 129 | $182.38 | $24K |
| 90966 ESRD Related Services (not dialysis) | Office | 93 | 12 | $248.34 | $23K |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 86 | 78 | $201.71 | $17K |
| 99213 Office E&M - Established | Office | 85 | 71 | $49.32 | $4,192 |
| 90961 ESRD Related Services (not dialysis) | Office | 70 | 19 | $245.45 | $17K |
| 90833 Psychotherapy - Nongroup | Office | 66 | 37 | $61.13 | $4,035 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 59 | 55 | $155.02 | $9,146 |
| 90960 ESRD Related Services (not dialysis) | Office | 55 | 17 | $299.03 | $16K |
| 99223 Hospital E&M - Initial | Facility | 49 | 45 | $124.88 | $6,119 |
| 99232 Hospital E&M - Subsequent | Facility | 39 | 29 | $65.75 | $2,564 |
| 90962 ESRD Related Services (not dialysis) | Office | 32 | 15 | $172.51 | $5,520 |
| 99204 Office E&M - New | Office | 31 | 31 | $144.21 | $4,470 |
By year: 2022 $294K for 2,155 services; 2023 $277K for 2,350 services; 2024 $340K for 2,915 services.
Medicare prescription drug claims, 2024
In 2024, the drug Eric Wechsler prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 299 prescriptions and refills. In total Eric Wechsler wrote 3,237 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 299 | 600 | 84 | $326K |
| Olmesartan Medoxomil Generic | 207 | 578 | 77 | $5,173 |
| Amlodipine Besylate Generic | 207 | 569 | 76 | $1,890 |
| Losartan Potassium Generic | 159 | 407 | 56 | $1,102 |
| Nebivolol Hcl Generic | 138 | 358 | 47 | $9,809 |
| Calcitriol Generic | 112 | 296 | 43 | $2,167 |
| Allopurinol Generic | 109 | 261 | 30 | $1,669 |
| Valsartan Generic | 86 | 245 | 28 | $2,094 |
| Hydralazine Hcl Generic | 79 | 226 | 30 | $1,558 |
| Spironolactone Generic | 72 | 180 | 29 | $646 |
| Dapagliflozin Dapagliflozin Propanediol | 67 | 88 | 22 | $42K |
| Furosemide Generic | 65 | 176 | 25 | $290 |
| Lisinopril Generic | 58 | 159 | 17 | $361 |
| Atorvastatin Calcium Generic | 55 | 147 | 21 | $551 |
| Carvedilol Generic | 48 | 113 | 15 | $325 |
Brand drugs: - claims; generic drugs: 2,440 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eric Wechsler $13K ($13K in general payments such as food, travel and fees) from 23 companies. The largest payer was GlaxoSmithKline, LLC. with $11K.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 4 | $11K |
| Ardelyx, Inc. ARDX | 14 | $324 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 17 | $298 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 10 | $272 |
| Calliditas Therapeutics US Inc. | 5 | $238 |
| Mallinckrodt Hospital Products Inc. | 7 | $176 |
| Vifor Pharma, Inc. | 6 | $158 |
| Apellis Pharmaceuticals, Inc. APLS | 7 | $155 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $117 |
| Travere Therapeutics, Inc. TVTX | 8 | $109 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.